Zum Hauptinhalt springen

NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme (ANCHIALE)

MagForce, USA ; Slawomir Michalak, MD, PhD, Prof., head of department
In: Stupp R, Mason WP, van den Bent MJ, Weller M, Fher B, Taphoorn MJ, Belanger K, Brandes AA, MarosC, Bogdahn U, Curschmann J, Janzer RC, Ludw SK, Gorl T, Allger A, Lacombe D, Cancross JG, Eenhauer E, Manoff RO; European Organatn for Research and Treatment of Cancer Bra Tumor and Radtherapy Groups; Natnal Cancer stute of Canada Clal Trls Group. Radtherapy plus concomant and adjuvant temozolome for glblastoma. N Engl J Med. 2005 Mar 10;352(10):987-96. do 10.1056/NEJMoa043330. Barker CA, Chang M, Chou JF, Zhang Z, Beal K, Gut PH, amoto FM. Radtherapy and concomant temozolome may prove surval of elderly patnts wh glblastoma. J Neurooncol. 2012 Sep;109(2):391-7. do 10.1007/s11060-012-0906-4. Epub 2012 Jun 12. Gupta T, Sar R. Poor-prognos hh-grade glmas: evolvg an evence-based standard of care. Lancet Oncol. 2002 Sep;3(9):557-64. do 10.1016/s1470-2045(02)00853-7. Erratum : Lancet Oncol 2002 Oct;3(10):592. Sun J, Guo M, Pang H, QJ, Zhang J, Ge Y. Treatment of malnant glma usg hypertherm. Neural Regen Res. 2013 Oct 15;8(29):2775-82. do 10.3969/j.sn.1673-5374.2013.29.009. MahmoudK, Bouras A, Bozec D, kov R, Hadjanay C. Magnet hypertherm therapy for the treatment of glblastoma: a revw of the therapy's htory, effacy and applatn humans. t J Hypertherm. 2018 Dec;34(8):1316-1328. do 10.1080/02656736.2018.1430867. Epub 2018 Feb 6. Mar-Hauff K, Ulrh F, Nestler D, Nhoff H, Wust P, Thsen B, Orawa H, Budach V, Jordan A. Effacy and safety of tratumoral thermotherapy usg magnet on-oxe nanopartles combed wh external beam radtherapy on patnts wh recurrent glblastoma multorme. J Neurooncol. 2011 Jun;103(2):317-24. do 10.1007/s11060-010-0389-0. Epub 2010 Sep 16. Pel S, Thomas N, Boura C, BarberHeyob M. Approaches to physal stulatn of metall nanopartles for glblastoma treatment. Adv Drug Del Rev. 2019 Jan 1;138:344-357. do 10.1016/j.addr.2018.10.013. Epub 2018 Nov 7. Boroon MP, AyanMB, Bazaz SR. Estatn of the optum number and locatn of nanopartle jectns and the spec loss power for eal hypertherm. J Therm Bl. 2018 Feb;72:127-136. do 10.1016/j.jtherb.2018.01.010. Epub 2018 Jan 31. Grauer O, Jaber M, Hess K, Weckesser M, Schwdt W, Marg S, Wolfer J, Stummer W. Combed tracavary thermotherapy wh on oxe nanopartles and radtherapy as local treatment modaly recurrent glblastoma patnts. J Neurooncol. 2019 Jan;141(1):83-94. do 10.1007/s11060-018-03005-x. Epub 2018 Dec 1. Huang H, Yu K, MohammadA, Karanthanas E, Godley A, Yu JS. 's Gettg Hot Here: Targetg Cancer Stem-le Cells wh Hypertherm. J Stem Cell Transplant Bl. 2017;2(2):113. Epub 2017 Dec 29. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weste AS, Fchbach AJ, Chang CH, Rotman M, Asbell SO, Krch RE, et al. Recurse partng analys of prognost factors three Radtn Therapy Oncology Group malnant glma trls. J Natl Cancer st. 1993 May 5;85(9):704-10. do 10.1093/jnc85.9.704. Dong X, Noorbakhsh A, Hshman BR, Zhou T, Tang JA, Chang DC, Carter BS, Chen CC. Surval trends of grade , and astrocytoma patnts and assocted clal practe patterns between 1999 and 2010: A SEER-based analys. Neurooncol Pract. 2016 Mar;3(1):29-38. do 10.1093/nop/npv016. Epub 2015 Jul 1. Gupta R, Sharma D. Evolutn of Magnet Hypertherm for Glblastoma Multorme Therapy. ACS Chem Neurosc 2019 Mar 20;10(3):1157-1172. do 10.1021/acschemneuro.8b00652. Epub 2019 Feb 19. HegME, L L, Herman JG, Stupp R, Wk W, Weller M, Mehta MP, Gbert MR. Correlatn of O6-methylguane methyltransferase (MGMT) promoter methylatn wh clal outcomes glblastoma and clal strategs to modulate MGMT acty. J Cl Oncol. 2008 Sep 1;26(25):4189-99. do 10.1200/JCO.2007.11.5964. Laperrre N, Zuraw L, Cancross G; Cancer Care Ontar Practe Gueles te Neuro-Oncology Dease Se Group. Radtherapy for newly dgnosed malnant glma adults: a systemat revw. Radther Oncol. 2002 Sep;64(3):259-73. do 10.1016/s0167-8140(02)00078-6. NwokedEC, Dse SJ, Jabbour S, Herman J, Am P, Ch LS. Gamma kne stereotact radsurgery for patnts wh glblastoma multorme. Neurosurgery. 2002 Jan;50(1):41-6; dcussn 46-7. do 10.1097/00006123-200201000-00009. Paszat L, Laperrre N, Groome P, Schulze K, Macklop W, Holowaty E. A populatn-based study of glblastoma multorme. t J Radt Oncol Bl Phys. 2001 Sep 1;51(1):100-7. do 10.1016/s0360-3016(01)01572-3. Stupp R, Talert S, Kanner A, Read W, Steberg D, Lhermte B, Toms S, ba A, Ahluwal MS, Fk K, DMeco F, Lberman F, Zhu JJ, Stragltto G, Tran D, Brem S, Hottger A, Kson ED, Lavy-Shahaf G, Weberg U, K CY, Paek SH, Nholas G, Bruna J, Hte H, Weller M, PaltY, HegME, Ram Z. Effect of Tumor-Treatg Flds Plus Matenance Temozolome vs Matenance Temozolome Alone on Surval Patnts Wh Glblastoma: A Randomed Clal Trl. JAMA. 2017 Dec 19;318(23):2306-2316. do 10.1001/jama.2017.18718. Erratum : JAMA. 2018 May 1;319(17):1824. Application of Nanoparticles for Cyclic Hyperthermia In Adjuvant Therapy of gLioblastoma Multiforme (ANCHIALE)
Online report

Titel:
NanoTherm In Adjuvant Therapy of Glioblastoma Multiforme (ANCHIALE)
Autor/in / Beteiligte Person: MagForce, USA ; Slawomir Michalak, MD, PhD, Prof., head of department
Link:
Quelle: Stupp R, Mason WP, van den Bent MJ, Weller M, Fher B, Taphoorn MJ, Belanger K, Brandes AA, MarosC, Bogdahn U, Curschmann J, Janzer RC, Ludw SK, Gorl T, Allger A, Lacombe D, Cancross JG, Eenhauer E, Manoff RO; European Organatn for Research and Treatment of Cancer Bra Tumor and Radtherapy Groups; Natnal Cancer stute of Canada Clal Trls Group. Radtherapy plus concomant and adjuvant temozolome for glblastoma. N Engl J Med. 2005 Mar 10;352(10):987-96. do 10.1056/NEJMoa043330. Barker CA, Chang M, Chou JF, Zhang Z, Beal K, Gut PH, amoto FM. Radtherapy and concomant temozolome may prove surval of elderly patnts wh glblastoma. J Neurooncol. 2012 Sep;109(2):391-7. do 10.1007/s11060-012-0906-4. Epub 2012 Jun 12. Gupta T, Sar R. Poor-prognos hh-grade glmas: evolvg an evence-based standard of care. Lancet Oncol. 2002 Sep;3(9):557-64. do 10.1016/s1470-2045(02)00853-7. Erratum : Lancet Oncol 2002 Oct;3(10):592. Sun J, Guo M, Pang H, QJ, Zhang J, Ge Y. Treatment of malnant glma usg hypertherm. Neural Regen Res. 2013 Oct 15;8(29):2775-82. do 10.3969/j.sn.1673-5374.2013.29.009. MahmoudK, Bouras A, Bozec D, kov R, Hadjanay C. Magnet hypertherm therapy for the treatment of glblastoma: a revw of the therapy's htory, effacy and applatn humans. t J Hypertherm. 2018 Dec;34(8):1316-1328. do 10.1080/02656736.2018.1430867. Epub 2018 Feb 6. Mar-Hauff K, Ulrh F, Nestler D, Nhoff H, Wust P, Thsen B, Orawa H, Budach V, Jordan A. Effacy and safety of tratumoral thermotherapy usg magnet on-oxe nanopartles combed wh external beam radtherapy on patnts wh recurrent glblastoma multorme. J Neurooncol. 2011 Jun;103(2):317-24. do 10.1007/s11060-010-0389-0. Epub 2010 Sep 16. Pel S, Thomas N, Boura C, BarberHeyob M. Approaches to physal stulatn of metall nanopartles for glblastoma treatment. Adv Drug Del Rev. 2019 Jan 1;138:344-357. do 10.1016/j.addr.2018.10.013. Epub 2018 Nov 7. Boroon MP, AyanMB, Bazaz SR. Estatn of the optum number and locatn of nanopartle jectns and the spec loss power for eal hypertherm. J Therm Bl. 2018 Feb;72:127-136. do 10.1016/j.jtherb.2018.01.010. Epub 2018 Jan 31. Grauer O, Jaber M, Hess K, Weckesser M, Schwdt W, Marg S, Wolfer J, Stummer W. Combed tracavary thermotherapy wh on oxe nanopartles and radtherapy as local treatment modaly recurrent glblastoma patnts. J Neurooncol. 2019 Jan;141(1):83-94. do 10.1007/s11060-018-03005-x. Epub 2018 Dec 1. Huang H, Yu K, MohammadA, Karanthanas E, Godley A, Yu JS. 's Gettg Hot Here: Targetg Cancer Stem-le Cells wh Hypertherm. J Stem Cell Transplant Bl. 2017;2(2):113. Epub 2017 Dec 29. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weste AS, Fchbach AJ, Chang CH, Rotman M, Asbell SO, Krch RE, et al. Recurse partng analys of prognost factors three Radtn Therapy Oncology Group malnant glma trls. J Natl Cancer st. 1993 May 5;85(9):704-10. do 10.1093/jnc85.9.704. Dong X, Noorbakhsh A, Hshman BR, Zhou T, Tang JA, Chang DC, Carter BS, Chen CC. Surval trends of grade , and astrocytoma patnts and assocted clal practe patterns between 1999 and 2010: A SEER-based analys. Neurooncol Pract. 2016 Mar;3(1):29-38. do 10.1093/nop/npv016. Epub 2015 Jul 1. Gupta R, Sharma D. Evolutn of Magnet Hypertherm for Glblastoma Multorme Therapy. ACS Chem Neurosc 2019 Mar 20;10(3):1157-1172. do 10.1021/acschemneuro.8b00652. Epub 2019 Feb 19. HegME, L L, Herman JG, Stupp R, Wk W, Weller M, Mehta MP, Gbert MR. Correlatn of O6-methylguane methyltransferase (MGMT) promoter methylatn wh clal outcomes glblastoma and clal strategs to modulate MGMT acty. J Cl Oncol. 2008 Sep 1;26(25):4189-99. do 10.1200/JCO.2007.11.5964. Laperrre N, Zuraw L, Cancross G; Cancer Care Ontar Practe Gueles te Neuro-Oncology Dease Se Group. Radtherapy for newly dgnosed malnant glma adults: a systemat revw. Radther Oncol. 2002 Sep;64(3):259-73. do 10.1016/s0167-8140(02)00078-6. NwokedEC, Dse SJ, Jabbour S, Herman J, Am P, Ch LS. Gamma kne stereotact radsurgery for patnts wh glblastoma multorme. Neurosurgery. 2002 Jan;50(1):41-6; dcussn 46-7. do 10.1097/00006123-200201000-00009. Paszat L, Laperrre N, Groome P, Schulze K, Macklop W, Holowaty E. A populatn-based study of glblastoma multorme. t J Radt Oncol Bl Phys. 2001 Sep 1;51(1):100-7. do 10.1016/s0360-3016(01)01572-3. Stupp R, Talert S, Kanner A, Read W, Steberg D, Lhermte B, Toms S, ba A, Ahluwal MS, Fk K, DMeco F, Lberman F, Zhu JJ, Stragltto G, Tran D, Brem S, Hottger A, Kson ED, Lavy-Shahaf G, Weberg U, K CY, Paek SH, Nholas G, Bruna J, Hte H, Weller M, PaltY, HegME, Ram Z. Effect of Tumor-Treatg Flds Plus Matenance Temozolome vs Matenance Temozolome Alone on Surval Patnts Wh Glblastoma: A Randomed Clal Trl. JAMA. 2017 Dec 19;318(23):2306-2316. do 10.1001/jama.2017.18718. Erratum : JAMA. 2018 May 1;319(17):1824. Application of Nanoparticles for Cyclic Hyperthermia In Adjuvant Therapy of gLioblastoma Multiforme (ANCHIALE)
Medientyp: report
DOI: 10.1016/j.inat.2021.101127
Sonstiges:
  • Nachgewiesen in: ClinicalTrials.gov
  • Sprachen: English

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -